DG,
Years ago, we all sat here and watched DNAP stock go to eighteen cents in one day as the news came out on the use of our forensics test to help catch the Louisiana serial murderer.
There will be no replay. Yet it is still good press for the company, in many respects.
There was another California case a couple years later that DNAP helped solve, and there was very little reaction both in the media and the stock price.
After being here for eight years, it is obvious that revenues will be the only factor that lifts DNAPrint off the floor. Your commitment to the company is to be commended, along with your patience exhibited in respect to the "naysayer".
Market Data 
Markets 
AI
